Aster DM Healthcare’s stock saw 2% increase after HSBC maintained a positive outlook for the company, raising the target price to ₹550.
HSBC has shown confidence in India’s hospital sector, forecasting significant growth with a focus on capacity expansion in 2025. Seven hospitals under coverage are expected to account for around 40% of the planned bed additions, signaling robust revenue growth.
Despite this optimism, HSBC warns that EBITDA margins may face some pressure due to increased capital expenditures associated with expansion. However, the overall revenue outlook remains strong, with the sector benefiting from rising healthcare demand.
Aster DM Healthcare shares opened at ₹502, with a daily high of ₹and a low of ₹490.10. The stock remains well within range of its 52-week high of ₹558 and low of ₹311.10, indicating healthy performance and investor confidence.
As of 10:41 am, Aster DM Healthcare shares were trading 2.41% higher at Rs 500.50 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
